Showing results (31-40 of 335) with videos related to
Sort By:
Pageof 34
Clinical Pharmacokinetics|March 10, 2018
Individualization of Irinotecan Treatment: A Review of Pharmacokinetics, Pharmacodynamics, and PharmacogeneticsFemke M de Man, Andrew K L Goey, Ron H N van Schaik, et al.Journal of Pharmaceutical and Biomedical Analysis|November 26, 2009
Bioanalytical method for the quantification of sunitinib and its n-desethyl metabolite SU12662 in human plasma by ultra performance liquid chromatography/tandem triple-quadrupole mass spectrometryPeter de Bruijn, Stefan Sleijfer, Mei-Ho Lam, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2007
Evaluation of alternate size descriptors for dose calculation of anticancer drugs in the obeseAlex Sparreboom, Antonio C Wolff, Ron H J Mathijssen, et al.Clinical Pharmacology and Therapeutics|December 14, 2004
Mechanism-based models for topotecan-induced neutropeniaFrédéric Léger, Walter J Loos, Roland Bugat, et al.Drugs|December 28, 2020
Inhibiting CDK4/6 in Breast Cancer with Palbociclib, Ribociclib, and Abemaciclib: Similarities and DifferencesC Louwrens Braal, Elisabeth M Jongbloed, Saskia M Wilting, et al.Pharmaceuticals (Basel, Switzerland)|February 9, 2021
Feasibility of Extrapolating Randomly Taken Plasma Samples to Trough Levels for Therapeutic Drug Monitoring Purposes of Small Molecule Kinase InhibitorsRuben A G van Eerden, Esther Oomen-de Hoop, Aad Noordam, et al.Hepatology Communications|June 11, 2022
Tamoxifen use and potential effects on liver parenchyma: A long-term prospective transient elastographic evaluationC Louwrens Braal, Robert J de Knegt, Agnes Jager, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2004
ABCG2 pharmacogenetics: ethnic differences in allele frequency and assessment of influence on irinotecan dispositionFloris A de Jong, Sharon Marsh, Ron H J Mathijssen, et al.Therapeutic Drug Monitoring|May 31, 2018
Development of an Enzyme-Linked Immune Sorbent Assay to Measure Nivolumab and Pembrolizumab Serum ConcentrationsEdwin A Basak, Annemarie J M Wijkhuijs, Ron H J Mathijssen, et al.Journal of Pharmaceutical and Biomedical Analysis|November 20, 2020
To quantify the small-molecule kinase inhibitors ceritinib, dacomitinib, lorlatinib, and nintedanib in human plasma by liquid chromatography/triple-quadrupole mass spectrometryG D Marijn Veerman, Peter de Bruijn, Anne-Marie C Dingemans, et al.Pageof 34